Related Experiment Video
Updated: Jun 23, 2026
06:13
Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults
Published on: December 1, 2023
A structured educational program improves metabolic control in patients with type 2 diabetes: a randomized controlled
Suzana Fiore Scain1, Rogério Friedman2, Jorge Luiz Gross2
1The Public Health Unit, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Brazil (Dr Scain)
The Diabetes Educator
|May 20, 2009
Summary
A structured education program significantly improved glycemic control in type 2 diabetes patients. This self-management approach showed lasting benefits for blood sugar levels for up to 12 months.
Area of Science:
- Endocrinology
- Diabetes Management
- Public Health
Background:
- Type 2 diabetes requires ongoing management to prevent complications.
- Structured education programs can empower patients with self-management skills.
- Assessing the long-term impact of such programs is crucial for optimizing care.
Purpose of the Study:
- To evaluate the effectiveness of a structured education group program on metabolic control in patients with type 2 diabetes.
- To determine the durability of the program's effects on glycemic control and other metabolic parameters.
Main Methods:
- A randomized controlled trial involving 104 patients with type 2 diabetes (excluding insulin users).
- Participants were assigned to either an 8-hour structured group education program or usual care.
- Outcomes including A1C, weight, blood pressure, and lipids were measured at 4-month intervals for up to 12 months.
Main Results:
- A1C levels significantly decreased in the intervention group from month 4 to month 12 compared to the control group.
- Improvements in weight, blood pressure, total cholesterol, and high-density lipoprotein levels were observed in both groups.
- The structured education program demonstrated a significant positive impact on glycemic control.
Conclusions:
- A structured, self-management-focused education group program effectively improves glycemic control in type 2 diabetes.
- The peak benefit on glycemic control was observed at 4 months and sustained for up to 12 months.
- This program represents a valuable tool for enhancing long-term diabetes management.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...